(Reuters) – U.S. antitrust officials have approved Spectrum Pharmaceuticals’ purchase of cancer drugmaker Allos Therapeutics, a $206 million deal aimed at giving Spectrum access to the Allos anti-cancer drug Folotyn.The Federal Trade Commission posted letters on its web site sent to lawyers for Allo

(Reuters) – Scientists have grown a drug to treat a rare genetic disease inside corn plants, potentially offering a cheaper way to manufacture a treatment that currently costs hundreds of thousands of dollars a year for each patient.The move marks an advance for the emerging field of molecular farmi

Nonthaburi, Thailand | November 25, 2022 – The Health Intervention and Technology Assessment Program (HITAP) announced the completion of the first Technical Workshop on Infectious Disease Modelling. Research staff from the London School of Hygiene and Tropical Medicine (LSHTM) with joint appointment